Fingolimod (FTY720), a sphingosine analog driving the internalization of S1PR1, decreased the recruitment of macrophages to the brain tumor microenvironment and induced a pro-inflammatory phenotype [87]. Here, S1PR1 is linked to brain neoplasm.